228 related articles for article (PubMed ID: 15794110)
21. Rapacuronium: first experience in clinical practice.
Bartkowski RR; Witkowski TA
Eur J Anaesthesiol Suppl; 2001; 23():90-3. PubMed ID: 11766254
[TBL] [Abstract][Full Text] [Related]
22. [Rapacuronium: a new, non-depolarizing muscle relaxant for rapid intubation?].
Busley R; Blobner M; Kochs E
Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Feb; 35(2):112-4. PubMed ID: 10719607
[No Abstract] [Full Text] [Related]
23. Vecuronium in a patient with late cerebellar cortical atrophy.
Oikawa M; Nitahara K; Shono S; Sakuragi T; Higa K
J Clin Anesth; 2006 Mar; 18(2):145-7. PubMed ID: 16563336
[TBL] [Abstract][Full Text] [Related]
24. [Monitoring of neuromuscular block and prevention of residual paralysis].
Fuchs-Buder T; Meistelman C
Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S46-50. PubMed ID: 19887277
[TBL] [Abstract][Full Text] [Related]
25. [Resistance to vecuronium induced muscle relaxation in a patient with mental retardation receiving phenytoin for chronic anticonvulsant therapy].
Kira S
Masui; 2011 Jan; 60(1):80-3. PubMed ID: 21348254
[TBL] [Abstract][Full Text] [Related]
26. Accidental epidural injection of vecuronium.
Kostopanagiotou G; Mylona M; Massoura L; Siafaka I
Anesth Analg; 2000 Dec; 91(6):1550-1, TOC. PubMed ID: 11094016
[TBL] [Abstract][Full Text] [Related]
27. The effects of the neuromuscular blockade levels on amplitudes of posttetanic motor-evoked potentials and movement in response to transcranial stimulation in patients receiving propofol and fentanyl anesthesia.
Yamamoto Y; Kawaguchi M; Hayashi H; Horiuchi T; Inoue S; Nakase H; Sakaki T; Furuya H
Anesth Analg; 2008 Mar; 106(3):930-4, table of contents. PubMed ID: 18292442
[TBL] [Abstract][Full Text] [Related]
28. Anaphylaxis during skin test with vecuronium.
Duman H; Dogru M; Misirlioglu F; Ozmen S; Bostanci I
Allergol Immunopathol (Madr); 2012; 40(1):61-2. PubMed ID: 21429653
[No Abstract] [Full Text] [Related]
29. Muscle relaxants in paediatric day case surgery.
Meakin GH
Eur J Anaesthesiol Suppl; 2001; 23():47-52. PubMed ID: 11766247
[TBL] [Abstract][Full Text] [Related]
30. Neuromuscular blocking drugs for the new millennium: current practice, future trends--comparative pharmacology of neuromuscular blocking drugs.
Donati F
Anesth Analg; 2000 May; 90(5 Suppl):S2-S6. PubMed ID: 10809511
[No Abstract] [Full Text] [Related]
31. Rapacuronium: clinical pharmacology.
Mirakhur RK; McCourt KC
Eur J Anaesthesiol Suppl; 2001; 23():77-82. PubMed ID: 11766252
[TBL] [Abstract][Full Text] [Related]
32. Neuromuscular transmission: new concepts and agents.
de Boer HD
J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537
[TBL] [Abstract][Full Text] [Related]
33. Emergency use of sugammadex after failure of standard reversal drugs.
Lenz A; Hill G; White PF
Anesth Analg; 2007 Mar; 104(3):585-6. PubMed ID: 17312213
[TBL] [Abstract][Full Text] [Related]
34. [Resistance to vecuronium--a case report].
Kentner R; Dick W
Anaesthesiol Reanim; 1997; 22(6):164-6. PubMed ID: 9487788
[TBL] [Abstract][Full Text] [Related]
35. Fast-track method in cardiac surgery: evaluation of risks and benefits of continuous administration technique.
Najafi M
Singapore Med J; 2008 Jun; 49(6):470-5. PubMed ID: 18581020
[TBL] [Abstract][Full Text] [Related]
36. Masseter muscle rigidity after vecuronium.
Jenkins JG
Eur J Anaesthesiol; 1999 Feb; 16(2):137-9. PubMed ID: 10101632
[TBL] [Abstract][Full Text] [Related]
37. [Anaphylactoid reaction to vecuronium].
Yagi T; Tanaka H; Yamamoto Y; Nomura T; Kobayashi H; Murakami S
Masui; 1993 Apr; 42(4):598-601. PubMed ID: 7686231
[TBL] [Abstract][Full Text] [Related]
38. Sensitivity to vecuronium after botulinum toxin administration.
Fiacchino F; Grandi L; Soliveri P; Carella F; Bricchi M
J Neurosurg Anesthesiol; 1997 Apr; 9(2):149-53. PubMed ID: 9100185
[TBL] [Abstract][Full Text] [Related]
39. [Neuromuscular rest blockades after a single dose of a mid-term muscle relaxant].
Schreiber JU
Anaesthesist; 2004 Oct; 53(10):1006-8. PubMed ID: 15205835
[No Abstract] [Full Text] [Related]
40. Prolongation of rapacuronium neuromuscular blockade by clindamycin and magnesium.
Sloan PA; Rasul M
Anesth Analg; 2002 Jan; 94(1):123-4, table of contents. PubMed ID: 11772813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
